MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi

Core Viewpoint - MeiraGTx Holdings plc has announced an underwritten offering of 12,500,000 ordinary shares at a price of $4.00 per share, aiming to raise gross proceeds of $50 million before expenses [1][2]. Group 1: Offering Details - The offering is led by Sanofi, which invested $30 million in MeiraGTx through this offering [2]. - Other participants include Perceptive Advisors and various institutional healthcare funds [2]. - BofA Securities is acting as the sole underwriter for the offering, which is expected to close around August 13, 2024, pending customary closing conditions [2]. Group 2: Regulatory Information - The ordinary shares are being offered under an effective shelf registration statement on Form S-3, filed with the SEC on December 21, 2023, and declared effective on December 29, 2023 [3]. - The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC [3].